EMA ramps up measures to reduce animal testing
Going forward, a task force under the European Medicines Agency (EMA) will advise developers on how to minimize animal testing during drug development.
BY MIKKEL AABENHUS HEMMINGSEN, TRANSLATED BY DANIEL PEDERSEN
Producers of new medicines will soon be able to receive free advice from the European Medicines Agency (EMA) on how to reduce animal testing when developing new medicines, the EMA writes in a statement.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
EMA starts evaluation of Moderna's booster application
For subscribers
